- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01491412
Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia
RECONNECT-S GAMMA : A Non-interventional Study to Observe Real-life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
This is an observational study describing the real-life antipsychotic treatment during the hospitalisation of the patients due to acute psychotic episode.
In this NIS subject's data will be collected at one visit at the moment of discharge from the hospital.
The results of the study would help to characterise the discrepancy between current clinical practice and treatment guidelines, indicating that atypical antipsychotics are preferable and should be used in monotherapy during acute psychotic episodes in subjects with schizophrenia. Available evidence have revealed a frequent use of first-generation antipsychotics, polypharmacy, intramuscular route of administration and use of atypical antipsychotics in doses lower than recommended in registered summary of product characteristics.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Budapest, Hongrie
- Research Site
-
Debrecen, Hongrie
- Research Site
-
Gyor, Hongrie
- Research Site
-
Kerepestarcsa, Hongrie
- Research Site
-
Nyiregyhaza, Hongrie
- Research Site
-
Szekesfehervar, Hongrie
- Research Site
-
Szekszard, Hongrie
- Research Site
-
-
-
-
-
Daugavpils, Lettonie
- Research Site
-
Jelgava, Lettonie
- Research Site
-
Liepaja, Lettonie
- Research Site
-
Riga, Lettonie
- Research Site
-
Strenci, Lettonie
- Research Site
-
-
-
-
-
Bucharest, Roumanie
- Research Site
-
Iasi, Roumanie
- Research Site
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Written Informed Consent has been obtained from the Subject and/or his/her legal representative (as per local regulatory requirements).
- Meet the diagnostic criteria for schizophrenia stated in The Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria
- Subject is hospitalised due to an acute psychotic episode
Exclusion Criteria:
- Current participation in any clinical trial.
- Previous enrolment in the present NIS (in case of recurrence occurred during the enrolment period)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
---|
Acute psychotic episode in schizophrenia
Subjects suffering from schizophrenia being discharged from the hospital following hospitalisation due to acute psychotic episode
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Description of used atypical antipsychotic(s) during hospitalisation
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
The data will be collected at one visit at the moment of discharge from the hospital.
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Description of the daily dosage of atypical antipsychotic(s) during hospitalisation
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
The data will be collected at one visit at the moment of discharge from the hospital.
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Description of mode of administration of atypical antipsychotic(s) during hospitalisation
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
The data will be collected at one visit at the moment of discharge from the hospital.
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Percent of patients with atypical antipsychotic as monotherapy
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Percent of patients with combinations of antipsychotics.
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Description of main criteria used for selection of an antipsychotic during hospitalisation.
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Description of the usage of psychometric scales in day to day practice, to evaluate the disease symptoms and thus the efficacy of treatment.
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Description of used concomitant psychiatric medication (other than atypical antipsychotic) during the hospitalization
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Description of the relationship between medication used during the hospitalization and maintenance therapy recommended upon discharge
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Description of the study population by collecting the following exploratory variables: demographic, educational, economical, social data, psychiatric and somatic health.
Délai: hospitalisation period, an expected average of 2 weeks (variable per patient)
|
hospitalisation period, an expected average of 2 weeks (variable per patient)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Radu TEODORESCU, Prof., Spitalul Clinic of Psychiatry named after Prof. Dr. Alexandru Obregia, Romania
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- NIS-NME-SER-2011/1
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .